Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

3.4K
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
3.4K
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

532
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
532
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

591
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
591
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

443
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
443
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

653
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
653

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Real-world use of abbreviated dual antiplatelet therapy after percutaneous coronary intervention among patients with high bleeding risk: Are guidelines followed? Insights from the FRANCE-PCI registry.

Archives of cardiovascular diseases·2026
Same author

Chronic Treatment with Renin-Angiotensin System Inhibitors at Hospital Admission is Associated with Improved Reperfusion and Mortality Among STEMI Patients Undergoing Mechanical Reperfusion: Insight from the ISACS-STEMI COVID-19 Registry.

Current vascular pharmacology·2026
Same author

Early outcomes of redo-TAVI with the SAPIEN 3 platform: the prospective, multicentre ReTAVI registry.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·2026
Same author

Persisting Sex Discrepancies in Short-Term Outcomes of Patients with ST-Segment Myocardial Infarction: Results of the ISACS-STEMI COVID-19 Registry.

Journal of clinical medicine·2026
Same author

Long-Term Clinical Outcomes of High-Risk Plaques with Negative fractional flow reserve: the PECTUS-obs study.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·2026
Same author

Predictors of Procedural and Clinical Outcomes Following Transcatheter Tricuspid Edge-to-Edge Repair: An Expert Overview.

JACC. Cardiovascular interventions·2026

関連する実験動画

Updated: Apr 29, 2026

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
12:17

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

11.3K

トランスキャテータ性大動脈弁の埋め込みと分断フロー・リザーブによる皮膚経冠動脈介入と,大動脈弁の置換と冠動脈バイパス移植による,大動脈弁の狭窄症および複合性または多血管性冠動脈疾患 (TCW)

Elvin Kedhi1, Renicus S Hermanides2, Jan-Henk E Dambrink2

  • 1Royal Victoria Hospital, McGill University Health Center, Montreal, QC, Canada; Department of Cardiology and Structural Heart Disease, Medical University of Silesia, Katowice, Poland.

Lancet (London, England)
|December 7, 2024
PubMed
まとめ

重度の大動脈狭窄症および複雑な冠動脈疾患では,FFR誘導PCIとTAVIの経皮治療はSAVRとCABGに劣らず優れ,より良い結果を示しています.

さらに関連する動画

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

11.6K
Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
05:31

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model

Published on: June 8, 2022

2.8K

関連する実験動画

Last Updated: Apr 29, 2026

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
12:17

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

11.3K
Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

11.6K
Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
05:31

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model

Published on: June 8, 2022

2.8K

科学分野:

  • 心臓病科
  • 介入心臓科
  • 心臓外科

背景:

  • 重度の大動脈狭窄は 閉塞性冠動脈疾患としばしば共存します
  • 現在のガイドラインは,手術による大動脈弁置換 (SAVR) と冠動脈バイパス移植 (CABG) を好みます.
  • 断片流量リザーブ (FFR) による皮膚経冠動脈干渉 (PCI) を用いたトランスキャテーター大動脈弁移植 (TAVI) は代替手段である.

研究 の 目的:

  • FFRによるPCI+TAVIとSAVR+CABGの劣等性を検証する.
  • 重度の大動脈狭窄症および複雑な冠動脈疾患の患者におけるこれらの併用治療の有効性と安全性を評価する.

主な方法:

  • 172人の患者 (≥70歳) を対象とした国際的,多センター,前向きな,ランダム化制御試験.
  • 患者はFFR誘導PCIとTAVIまたはSAVRとCABGに1対1でランダムに割り当てられました.
  • 1年後の死亡率,心筋梗塞,脳卒中,再血管化,弁再介入,出血を総合した結果でした.

主要な成果:

  • FFRによるPCIとTAVIは,好ましいプライマリエンドポイントの結果を示し (4%対23%),非劣等性を示した (p<0. 001).
  • この皮膚経によるアプローチはSAVRとCABG (HR 0. 17,p< 0. 001) よりも優れていた.
  • 優位性は,全因死亡率 (全因死亡率0%,全因死亡率10%) と生命を脅かす出血率 (全因死亡率2%,全因出血率12%) の低下によるものである.

結論:

  • FFRによるPCI + TAVIは,SAVR + CABGの安全で効果的な代替手段です.
  • この皮膚経路は 死亡率を高め 出血の合併症を軽減します
  • この患者集団における皮膚経由治療による好ましい結果を示す最初の試験です.